Skip to main content
. 2022 Sep 8;23(18):10384. doi: 10.3390/ijms231810384

Figure 3.

Figure 3

Distribution of efficacy levels of compound categories 1 to 5. On the total number of trials included in each category, expressed are the percentages of trials classified as an analgesic effect (vs. a control group), an improvement over time of the treatment group or a non-effect of the treatment. Ctg. 1 (omega-3-enriched therapeutic diets), ctg. 2 (omega-3-based nutraceuticals), ctg. 3 (collagen-based nutraceuticals), ctg. 4 (chondroitin-glucosamine-based nutraceuticals) and ctg. 5 (cannabinoid-based nutraceuticals). Ctg., category.